🏅 FDA Orphan Designation

Rifater

Rifampin, isoniazid, pyrazinamide

Manufacturer: Hoechst Marion Roussel

Indicated for:

Primary cutaneous tuberculosisOrphan

FDA-Approved Indications (1)

Primary cutaneous tuberculosisOrphan Designation

Short-course treatment of tuberculosis.

Indications & Usage

Short-course treatment of tuberculosis.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.